sepsi
usual
progress
quickli
sever
sepsi
septic
shock
main
caus
death
noncardiac
critic
patient
patient
sepsi
appear
vari
degre
myocardi
depress
mortal
high
research
report
myocardi
organ
damag
exist
earli
sepsi
low
blood
pressur
arrhythmia
heart
failur
easili
appear
patient
therefor
import
signific
time
administ
effect
medicin
patient
septic
myocardi
injuri
tradit
medicin
treatment
infecti
diseas
long
histori
xuebij
inject
anintraven
solut
prepar
formula
tradit
chines
medicin
tcm
formula
consist
chishao
radix
paeonia
rubra
danggui
radix
angelica
sinensi
chuanxiong
rhizoma
chuanxiong
honghua
flo
carthami
danshen
radix
salvia
miltiorrhiza
efficaci
activ
blood
circul
remov
blood
stasi
cool
blood
clear
toxic
heat
xuebij
inject
initi
use
treatment
sever
acut
respiratori
syndrom
sar
caus
coronaviru
today
wide
use
kind
critic
ill
patient
includ
endotoxemia
circulatori
respiratori
failur
multipl
organ
dysfunct
use
xuebij
inject
patient
septic
myocardi
injuri
observ
effect
level
cardiac
troponin
ctni
ntermin
probtyp
natriuret
peptid
ntprobnp
procalcitonin
pct
explor
protect
effect
myocardi
injuri
patient
januari
decemb
total
patient
septic
myocardi
injuri
elect
intens
care
unit
second
hospit
tangshan
peopl
hospit
tangshan
age
patient
rang
form
year
old
patient
diagnos
accord
sepsi
diagnost
criteria
recommend
intern
sepsi
confer
decemb
age
patient
less
year
old
patient
cancer
blood
diseas
rheumat
diseas
acquir
immun
defici
syndrom
rule
elect
patient
histori
previou
cardiac
surgeri
myocardi
infarct
heart
failur
coronari
heart
diseas
cardiomyopathi
rule
addit
patient
occur
chest
compress
defibril
ordirect
current
cardiovers
day
elect
rule
studi
approv
ethic
committe
second
hospit
tangshan
peopl
hospit
tangshan
treatment
obtain
inform
consent
patient
famili
sign
agreement
studi
random
doubleblind
placebocontrol
trial
proport
two
sampl
accord
formula
minimum
sampl
size
calcul
take
twosid
take
onesid
minimum
patient
group
would
need
total
patient
estim
studi
consid
exclus
patient
fail
particip
followup
drop
trial
accord
admiss
order
intens
care
unit
icu
patient
obtain
serial
number
serial
number
divid
two
group
statist
softwar
spss
spss
softwar
inc
chicago
il
usa
distribut
ratio
two
group
outcom
measur
perform
independ
researchist
inform
treatment
sequenc
treatment
patient
would
receiv
therefor
research
particip
unawar
kind
inject
given
particip
treatment
drug
xuebij
inject
control
drug
sodium
chlorid
inject
use
opaqu
bag
outsid
blind
patient
two
group
receiv
convent
cluster
treatment
accord
intern
guidelin
criteria
convent
cluster
treatment
includ
treatment
primari
diseas
blood
fluid
transfus
protect
mechan
ventil
analges
sed
antiinflammatori
antiinfect
medic
nutrit
support
water
electrolyt
balanc
maintain
patient
treatment
group
addit
receiv
xuebij
inject
tianjin
chase
sun
pharmaceut
co
ltd
tianjin
china
applic
ml
xuebij
inject
dissolv
ml
sodium
chlorid
inject
administ
intraven
infus
timesday
start
day
diagnosi
confirm
treatment
xuebij
inject
last
day
patient
control
group
addit
receiv
amount
sodium
chlorid
inject
begin
treatment
treatment
laboratori
indic
ctni
ntprobnp
pct
respect
test
venou
blood
patient
length
stay
icu
mortal
day
record
detect
reagent
ctni
ntprobnp
pct
provid
getein
biotechnolog
co
ltd
nanj
china
outcom
measur
collect
investig
continu
aid
maintain
standard
procedur
safeti
assess
includ
investig
inquiri
occurr
advers
event
dizzi
palpit
nausea
diarrhea
skin
allergi
routin
inspect
blood
urin
stool
liverkidney
function
test
taken
treatment
statist
softwar
spss
spss
softwar
inc
chicago
il
usa
use
analyz
data
measur
data
present
mean
standard
deviat
x
student
test
perform
test
differ
two
group
p
signific
level
seventyfour
patient
septic
myocardi
injuri
elect
patient
famili
agre
particip
research
two
patient
exclud
accord
admiss
order
icu
patient
obtain
serial
number
serial
number
divid
treatment
group
case
control
group
case
computergener
randomli
two
patient
treatment
group
drop
patient
poor
complianc
would
coordin
outcom
measur
one
patient
control
group
gave
patient
satisfi
treatment
flow
diagram
studi
design
depict
figur
begin
treatment
statist
signific
differ
two
group
term
gender
age
primari
lesion
past
histori
acut
physiolog
chronic
health
evalu
apach
mortal
day
respect
mortal
treatment
group
lower
control
group
differ
statist
signific
length
stay
icu
treatment
group
less
control
group
differ
statist
signific
tabl
advers
event
record
studi
medic
ctni
begin
treatment
day
statist
signific
differ
two
group
term
ctni
p
treatment
level
ctni
treatment
group
lower
control
group
differ
statist
signific
p
figur
begin
treatment
day
statist
signific
differ
two
group
term
ntprobnp
p
treatment
level
ntprobnp
treatment
group
lower
control
group
differ
statist
signific
p
figur
begin
treatment
day
statist
signific
differ
two
group
term
pct
p
treatment
level
pct
treatment
group
lower
control
group
differ
statist
signific
p
figur
studi
investig
effect
xuebij
inject
myocardi
injuri
patient
sepsi
term
ctni
ntprobnp
pct
icu
length
stay
mortal
day
ctni
structur
protein
striat
muscl
exist
myocardi
cell
influenc
activ
atpas
bind
calcium
ion
regul
interact
actin
myosin
induc
myocardi
contract
relax
btype
natriuret
peptid
bnp
neuropeptid
hormon
secret
ventricular
myocyt
role
promot
sodium
diuresi
expand
blood
vessel
ventricular
myocyt
endur
stretch
probnp
rapidli
releas
blood
cleav
molar
amount
biolog
activ
bnp
inact
ntprobnp
pct
glycoprotein
low
healthi
human
blood
hardli
detect
pct
ideal
indic
inflamm
best
marker
clinic
diagnosi
sepsi
pct
significantli
increas
sever
bacteri
infect
increas
local
infect
viral
infect
chronic
nonspecif
inflamm
cancer
fever
autoimmun
diseas
comparison
inflammatori
marker
clinic
studi
suggest
xuebij
inject
effect
antagon
endotoxin
adjust
immun
respons
antagon
inflammatori
cytokin
improv
microcircul
protect
endotheli
cell
studi
treatment
level
ctni
ntprobnp
pct
treatment
group
improv
better
control
group
differ
statist
signific
p
chang
trend
three
marker
similar
result
illustr
xuebij
inject
protect
effect
septic
myocardi
injuri
time
could
improv
prognosi
patient
sepsi
addit
length
stay
icu
treatment
group
shorter
control
group
differ
statist
signific
conclus
xuebij
inject
improv
prognosi
patient
sepsi
import
limit
studi
twocent
control
trial
studi
multicent
control
trial
need
confirm
effect
xuebij
inject
septic
myocardi
injuri
addit
studi
preliminari
studi
necessari
extend
time
observ
accur
evalu
effect
xuebij
inject
futur
research
figur
comparison
procalcitonin
treatment
group
control
group
patient
two
group
receiv
convent
cluster
treatment
patient
treatment
group
addit
receiv
xuebij
inject
ml
xuebij
inject
dissolv
ml
sodium
chlorid
inject
administ
intraven
infus
timesday
day
patient
control
group
addit
receiv
amount
sodium
chlorid
inject
compar
control
group
p
figur
comparison
ntermin
probtyp
natriuret
peptid
treatment
group
control
group
patient
two
group
receiv
convent
cluster
treatment
patient
treatment
group
addit
receiv
xuebij
inject
ml
xuebij
inject
dissolv
ml
sodium
chlorid
inject
administ
intraven
infus
timesday
day
patient
control
group
addit
receiv
amount
sodium
chlorid
inject
compar
control
group
p
figur
comparison
cardiac
troponin
treatment
group
control
group
patient
two
group
receiv
convent
cluster
treatment
patient
treatment
group
addit
receiv
xuebij
inject
ml
xuebij
inject
dissolv
ml
sodium
chlorid
inject
administ
intraven
infus
timesday
day
patient
control
group
addit
receiv
amount
sodium
chlorid
inject
compar
control
group
p
